rs121918106
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 9P and 4B. PVS1_SupportingPP5_Very_StrongBS2
The NM_002778.4(PSAP):c.1A>T(p.Met1?) variant causes a initiator codon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000645 in 1,550,968 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_002778.4 initiator_codon
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PSAP | NM_002778.4 | c.1A>T | p.Met1? | initiator_codon_variant | Exon 1 of 14 | ENST00000394936.8 | NP_002769.1 | |
PSAP | NM_001042465.3 | c.1A>T | p.Met1? | initiator_codon_variant | Exon 1 of 15 | NP_001035930.1 | ||
PSAP | NM_001042466.3 | c.1A>T | p.Met1? | initiator_codon_variant | Exon 1 of 15 | NP_001035931.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152258Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000129 AC: 2AN: 154492Hom.: 0 AF XY: 0.0000245 AC XY: 2AN XY: 81696
GnomAD4 exome AF: 0.00000643 AC: 9AN: 1398710Hom.: 0 Cov.: 31 AF XY: 0.00000725 AC XY: 5AN XY: 689912
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152258Hom.: 0 Cov.: 34 AF XY: 0.0000134 AC XY: 1AN XY: 74390
ClinVar
Submissions by phenotype
Gaucher disease due to saposin C deficiency Pathogenic:2
- -
This sequence change in PSAP may cause a truncated or absent protein by altering the start codon of the coding sequence and is predicted to lead to the omission of a critical region of the protein (PMID: 17616409, 17919309; ClinVar: SCV001231459.2, SCV001590882.1). The highest population minor allele frequency in gnomAD v2.1 is 0.004% (3/74,284 alleles) in the European (non-Finnish) population. This variant has been detected in at least five individuals with PSAP-related disorders with prosaposin deficiency from three unrelated families. Of those individuals, three individuals were homozygous and two siblings were compound heterozygous for the variant and a variant of uncertain significance, confirmed in trans (PMID: 1371116, 15944902, 17919309). Patients with this variant have displayed saposin C deficiency or combined saposin deficiency in fibroblasts/cell extracts (PMID: 1371116, 20484222). Based on the classification scheme RMH Modified ACMG Guidelines v1.5.1, this variant is classified as PATHOGENIC. Following criteria are met: PVS1_Strong, PM3, PP1_Moderate, PM2_Supporting, PP4. -
Combined PSAP deficiency Pathogenic:1
- -
Sphingolipid activator protein 1 deficiency Pathogenic:1
Disruption of the initiator codon has been observed in individuals with PSAP-related conditions (PMID: 1371116, 17616409, 20484222). This sequence change affects the initiator methionine of the PSAP mRNA. The next in-frame methionine is located at codon 76. This variant is present in population databases (rs121918106, gnomAD 0.004%). This variant is also known as M1L. ClinVar contains an entry for this variant (Variation ID: 13365). Studies have shown that disruption of the initiator codon alters PSAP gene expression (PMID: 20484222). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at